RNA NanoMed, ISRNN Press.org

ISRNN Press

We are dedicated to promoting academic publishing, cultural exchange, and intellectual collaboration.


Our press serves scholars, writers, and professionals by providing a platform for high-quality publications.

About Us

Publications

We publish a journal of RNANAOMED.
Our goal is to support knowledge dissemination and showcase outstanding scholarly achievements.

Editorial for the Inaugural Issue

The recent discovery of the critical role of  RNA in biological systems has revolutionized our understanding of molecular biology. It was found that only 1.5% of the human genome encodes for proteins, while the remaining 98.5% of the human genome mainly codes for small or long non-coding RNA. These unexpected findings have significantly transformed life sciences. Recent FDA approval of RNAi drugs and COVID-19 mRNA vaccines has highlighted the potential of RNA therapeutics in clinics. These breakthroughs underscore RNA's emergence as a cornerstone of modern medicine, as documented by Nobel Prize awards in Medicine or Physiology in 2023 and 2024. I am pleased that my 2014 publication predicted that RNA would be the third milestone in pharmaceutical drug development, which is now being realized.